It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
The patients undergoing orthopedic surgery may have many risk factors of Clostridium difficile infection (CDI), including increased age, multiple underlying comorbidities, the use of perioperative antibiotics, and prolonged length of stay. The aim of this study was to identify prevalence, risk factor, and outcome of postoperative CDI in patients who underwent orthopedic surgery.
Methods
We performed a retrospective cohort study including all patients aged ≥18 years who underwent orthopedic surgery from January 2016 through December 2017 in a tertiary care hospital in Seoul, South Korea.
Results
During the study period, 7,369 episodes of orthopedic surgery were identified. The prevalence of C. difficile infection was 7.7 cases per 1,000 surgical procedures (95% confidence interval, 6.0–10.0). The risk of CDI was the highest among patients who underwent spine surgery (33.8 cases per 1,000 surgical procedures), followed by hip/femur surgery (12.4), knee (3.8), and extremity (3.2). The risk of CDI increased according to the increase in duration of proton pump inhibitor: 0.1% (no use), 0.3% (1–7 days), and 2.7% (>7 days, P < 0.001). The independent risk factors associated with postoperative CDI were age (odds ratio [OR] per 1-year increase, 1.04; P < 0.001), Charlson comorbidity index score (OR per 1-point increase, 1.26; P < 0.001), duration of proton pump inhibitor (OR per 1-day increase, 1.02; P < 0.001), and operation time (OR per 1-hour increase, 1.30; P = 0.003). Of 6,724 episodes of surgical procedure for which patients received exclusively perioperative antibacterial prophylaxis, 22 episodes of postoperative CDI occurred (3.2 cases per 1,000 surgical procedures). Among this subgroup, the risk of CDI increased according to increase in duration of antibacterial prophylaxis: 0% (<24 hour), 0.28% (1–7 days), and 1.27 (>7 days; P < 0.001). After adjusting confounding factors, duration of perioperative antibacterial prophylaxis remained a significant risk factor for postoperative CDI (OR per 1-day increase, 1.11; P < 0.001). Patients with CDI had a higher rate of postoperative mortality (10.5% vs. 0.6%; P < 0.001) and an increased length of hospital stay (mean 42 vs. 10 days; P < 0.001).
Conclusion
Judicious use of proton pump inhibitor and avoiding of extension of prophylactic antibiotics can reduce postoperative CDI after orthopedic surgery.
Disclosures
All authors: No reported disclosures.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul, Korea, Republic of (South)
2 Department of Laboratory Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul, Korea, Republic of (South)